Protective cellular retroviral immunity requires both CD4+ and CD8+ immune T cells.
We have found previously that postexposure chemoprophylaxis with 3'-azido-3'-deoxythymidine (also known as zidovudine or AZT) in combination with recombinant human alpha A/D interferon fully protected mice exposed to a lethal dose of Rauscher murine leukemia virus (RLV) against viremia and disease....
שמור ב:
| הוצא לאור ב: | J Virol |
|---|---|
| Principais autores: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1991
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC240508/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1898666/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.65.1.220-224.1991 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
